| Organism name | Pelteobagrus nudiceps | 
|---|---|
| Genus | Pelteobagrus | 
| Family | Bagridae | 
| Kingdom | Animalia | 
| Linked NCBI taxonomy name | Pelteobagrus | 
|---|---|
| Linked NCBI taxonomy ID | 175790 | 
| Linked level | genus | 
| Family in NCBI taxonomy | Bagridae | 
|---|---|
| ID | 31013 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Metazoa | 
|---|---|
| ID | 33208 | 
| Plant class | |
|---|---|
| ID | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00000918   | Astaxanthin / (3S,3'S)-3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione | CHEMBL445751 CHEMBL1358053 | C005948 | 1 / 4 / 3 | 0 / 7 | No. 26 | No. 59 |   | 
| C00000919   | beta-Carotene | CHEMBL1293 CHEMBL1966639 | D019207 | 7 / 12 / 11 | 104 / 19 | No. 26 | No. 59 |   | 
| C00000920   | beta-Cryptoxanthin | C010564 | No. 26 | No. 59 |   | |||
| C00000931   | Zeaxanthin / all-trans-Zeaxanthin | CHEMBL1357855 CHEMBL2359248 | C005881 | 4 / 2 / 3 | 1 / 0 | No. 26 | No. 59 |   | 
| C00003776   | Lutein / (all-E)-Lutein / all-trans-(+)-Xanthophyll / (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol | CHEMBL173929 CHEMBL172477 CHEMBL1559643 CHEMBL1979448 | D014975 | 4 / 2 / 3 | 7 / 2 | No. 26 | No. 59 |   | 
| C00022862   | Alloxanthin / Cynthiaxanthin / Pectenoxanthin / (3R,3'R)-7,7',8,8'-Tetradehydro-beta,beta-carotene-3,3'-diol | C006462 | No. 26 | No. 59 |   | |||
| C00022863   | Diatoxanthin / (3R,3'R)-7,8-Didehydro-beta,beta-carotene-3,3'-diol | C103105 | No. 26 | No. 59 |   | |||
| C00022910   | (3S,3'R,4R)-beta,beta-Carotene-3,3',4-triol | No. 26 | No. 59 |   | ||||
| C00023218   | (3R,3'S)-Zeaxanthin | CHEMBL1357855 CHEMBL2359248 | 4 / 2 / 3 | No. 26 | No. 59 |   | ||
| C00023219   | (3S,3'S)-Zeaxanthin | CHEMBL1357855 CHEMBL2359248 | 4 / 2 / 3 | No. 26 | No. 59 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| O75496 | Geminin | Unclassified protein | C00000919 C00000931 C00003776 C00023218 C00023219 | 0 / 0 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000931 C00003776 C00023218 C00023219 | 0 / 0 | 
| P11473 | Vitamin D3 receptor | NR1I1 | C00000931 C00003776 C00023218 C00023219 | 2 / 3 | 
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000931 C00003776 C00023218 C00023219 | 0 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00000919 | 11 / 10 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000919 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00000918 | 4 / 3 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00000919 | 0 / 0 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000919 | 0 / 1 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000919 | 1 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000919 | 0 / 0 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00000919
                          C00003776 | 
| 3110 | MNX1, HB9, HLXB9, HOXHB9, SCRA1 | motor neuron and pancreas homeobox 1 | C00000919 | 
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 | C00003776 | 
| 598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 | C00003776 | 
| 847 | CAT | catalase (EC:1.11.1.6) | C00003776 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00003776 | 
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00003776 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00003776 | 
| 124 | ADH1A, ADH1 | alcohol dehydrogenase 1A (class I), alpha polypeptide (EC:1.1.1.1) | C00000919 | 
| 128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) | C00000919 | 
| 221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) | C00000919 | 
| 8659 | ALDH4A1, ALDH4, P5CD, P5CDh | aldehyde dehydrogenase 4 family, member A1 (EC:1.2.1.88) | C00000919 | 
| 287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal | C00000919 | 
| 288 | ANK3, ANKYRIN-G, MRT37 | ankyrin 3, node of Ranvier (ankyrin G) | C00000919 | 
| 427 | ASAH1, AC, ACDase, ASAH, PHP, PHP32, SMAPME | N-acylsphingosine amidohydrolase (acid ceramidase) 1 (EC:3.5.1.23) | C00000919 | 
| 51665 | ASB1, ASB-1 | ankyrin repeat and SOCS box containing 1 | C00000919 | 
| 140462 | ASB9 | ankyrin repeat and SOCS box containing 9 | C00000919 | 
| 9531 | BAG3, BAG-3, BIS, CAIR-1, MFM6 | BCL2-associated athanogene 3 | C00000919 | 
| 9530 | BAG4, BAG-4, SODD | BCL2-associated athanogene 4 | C00000919 | 
| 9529 | BAG5, BAG-5 | BCL2-associated athanogene 5 | C00000919 | 
| 53630 | BCMO1, BCDO, BCDO1, BCMO, BCO, BCO1 | beta-carotene 15,15'-monooxygenase 1 (EC:1.14.99.36) | C00000919 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00000919 | 
| 999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) | C00000919 | 
| 8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator | C00000919 | 
| 9071 | CLDN10, CPETRL3, OSP-L | claudin 10 | C00000919 | 
| 51208 | CLDN18, SFTA5, SFTPJ | claudin 18 | C00000919 | 
| 1277 | COL1A1, OI4 | collagen, type I, alpha 1 | C00000919 | 
| 1282 | COL4A1, HANAC, ICH, POREN1, arresten | collagen, type IV, alpha 1 | C00000919 | 
| 1284 | COL4A2, ICH, POREN2 | collagen, type IV, alpha 2 | C00000919 | 
| 8738 | CRADD, MRT34, RAIDD | CASP2 and RIPK1 domain containing adaptor with death domain | C00000919 | 
| 1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) | C00000919 | 
| 6387 | CXCL12, IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1, SDF1A, SDF1B | chemokine (C-X-C motif) ligand 12 | C00000919 | 
| 6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 | C00000919 | 
| 4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 | C00000919 | 
| 7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 | C00000919 | 
| 1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) | C00000919 | 
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | C00000919 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00000919 | 
| 64816 | CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 (EC:1.14.14.1) | C00000919 | 
| 1746 | DLX2, TES-1, TES1 | distal-less homeobox 2 | C00000919 | 
| 1748 | DLX4, BP1, DLX7, DLX8, DLX9 | distal-less homeobox 4 | C00000919 | 
| 2068 | ERCC2, COFS2, EM9, TTD, XPD | excision repair cross-complementing rodent repair deficiency, complementation group 2 (EC:3.6.4.12) | C00000919 | 
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 | C00000919 | 
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) | C00000919 | 
| 23017 | FAIM2, LFG, LFG2, NGP35, NMP35, TMBIM2 | Fas apoptotic inhibitory molecule 2 | C00000919 | 
| 355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor | C00000919 | 
| 3169 | FOXA1, HNF3A, TCF3A | forkhead box A1 | C00000919 | 
| 2627 | GATA6 | GATA binding protein 6 | C00000919 | 
| 2633 | GBP1 | guanylate binding protein 1, interferon-inducible | C00000919 | 
| 81025 | GJA9, CX58, CX59, GJA10 | gap junction protein, alpha 9, 59kDa | C00000919 | 
| 373156 | GSTK1, GST, GST_13-13, GST13, GST13-13, GSTK1-1, hGSTK1 | glutathione S-transferase kappa 1 (EC:2.5.1.18) | C00000919 | 
| 2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) | C00000919 | 
| 2948 | GSTM4, GSTM4-4, GTM4 | glutathione S-transferase mu 4 (EC:2.5.1.18) | C00000919 | 
| 2949 | GSTM5, GSTM5-5, GTM5 | glutathione S-transferase mu 5 (EC:2.5.1.18) | C00000919 | 
| 2954 | GSTZ1, GSTZ1-1, MAAI, MAI | glutathione S-transferase zeta 1 (EC:2.5.1.18 5.2.1.2) | C00000919 | 
| 3204 | HOXA7, ANTP, HOX1, HOX1.1, HOX1A | homeobox A7 | C00000919 | 
| 3216 | HOXB6, HOX2, HOX2B, HU-2, Hox-2.2 | homeobox B6 | C00000919 | 
| 3226 | HOXC10, HOX3I | homeobox C10 | C00000919 | 
| 3448 | IFNA14, IFN-alphaH, LEIF2H | interferon, alpha 14 | C00000919 | 
| 3449 | IFNA16, IFN-alphaO | interferon, alpha 16 | C00000919 | 
| 3451 | IFNA17, IFN-alphaI, IFNA, INFA, LEIF2C1 | interferon, alpha 17 | C00000919 | 
| 3442 | IFNA5, IFN-alpha-5, IFN-alphaG, INA5, INFA5, leIF_G | interferon, alpha 5 | C00000919 | 
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta | C00000919 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00000919 | 
| 3394 | IRF8, H-ICSBP, ICSBP, ICSBP1, IRF-8 | interferon regulatory factor 8 | C00000919 | 
| 50805 | IRX4, IRXA3 | iroquois homeobox 4 | C00000919 | 
| 3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | C00000919 | 
| 3691 | ITGB4, CD104 | integrin, beta 4 | C00000919 | 
| 3713 | IVL | involucrin | C00000919 | 
| 3875 | KRT18, CYK18, K18 | keratin 18 | C00000919 | 
| 3880 | KRT19, CK19, K19, K1CS | keratin 19 | C00000919 | 
| 3849 | KRT2, CK-2e, K2e, KRT2A, KRT2E, KRTE | keratin 2 | C00000919 | 
| 3855 | KRT7, CK7, K2C7, K7, SCL | keratin 7 | C00000919 | 
| 3856 | KRT8, CARD2, CK-8, CK8, CYK8, K2C8, K8, KO | keratin 8 | C00000919 | 
| 8022 | LHX3, CPHD3, LIM3, M2-LHX3 | LIM homeobox 3 | C00000919 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00000919 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00000919 | 
| 4153 | MBL2, COLEC1, HSMBPC, MBL, MBL2D, MBP, MBP-C, MBP1, MBPD | mannose-binding lectin (protein C) 2, soluble | C00000919 | 
| 4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) | C00000919 | 
| 4212 | MEIS2, HsT18361, MRG1 | Meis homeobox 2 | C00000919 | 
| 4222 | MEOX1, KFS2, MOX1 | mesenchyme homeobox 1 | C00000919 | 
| 4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) | C00000919 | 
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) | C00000931 | 
| 4439 | MSH5, G7, MUTSH5, NG23 | mutS homolog 5 | C00000919 | 
| 4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming | C00000919 | 
| 4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) | C00000919 | 
| 8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 | C00000919 | 
| 4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 | C00000919 | 
| 5098 | PCDHGC3, PC43, PCDH-GAMMA-C3, PCDH2 | protocadherin gamma subfamily C, 3 | C00000919 | 
| 5359 | PLSCR1, MMTRA1B | phospholipid scramblase 1 | C00000919 | 
| 57048 | PLSCR3 | phospholipid scramblase 3 | C00000919 | 
| 57088 | PLSCR4, TRA1 | phospholipid scramblase 4 | C00000919 | 
| 10635 | RAD51AP1, PIR51 | RAD51 associated protein 1 | C00000919 | 
| 5892 | RAD51D, BROVCA4, R51H3, RAD51L3, TRAD | RAD51 paralog D | C00000919 | 
| 5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha | C00000919 | 
| 5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta | C00000919 | 
| 5918 | RARRES1, LXNL, TIG1 | retinoic acid receptor responder (tazarotene induced) 1 | C00000919 | 
| 5950 | RBP4, RDCCAS | retinol binding protein 4, plasma | C00000919 | 
| 6256 | RXRA, NR2B1 | retinoid X receptor, alpha | C00000919 | 
| 949 | SCARB1, CD36L1, CLA-1, CLA1, HDLQTL6, SR-BI, SRB1 | scavenger receptor class B, member 1 | C00000919 | 
| 4990 | SIX6, MCOPCT2, OPTX2, Six9 | SIX homeobox 6 | C00000919 | 
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) | C00000919 | 
| 9517 | SPTLC2, HSN1C, LCB2, LCB2A, NSAN1C, SPT2, hLCB2a | serine palmitoyltransferase, long chain base subunit 2 (EC:2.3.1.50) | C00000919 | 
| 6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 | C00000919 | 
| 7052 | TGM2, G-ALPHA-h, GNAH, TG2, TGC | transglutaminase 2 (EC:2.3.2.13) | C00000919 | 
| 7047 | TGM4, TGP, hTGP | transglutaminase 4 (EC:2.3.2.13) | C00000919 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00000919 | 
| 3604 | TNFRSF9, 4-1BB, CD137, CDw137, ILA | tumor necrosis factor receptor superfamily, member 9 | C00000919 | 
| 8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 | C00000919 | 
| 10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 | C00000919 | 
| 7517 | XRCC3, CMM6 | X-ray repair complementing defective repair in Chinese hamster cells 3 | C00000919 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #607948 | Mycobacterium tuberculosis, susceptibility to | P11473 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #172700 | Pick disease of brain | P10636 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a | P11473 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00342 | Tuberculosis | P11473
                            (related) | 
| H00784 | Localized autosomal recessive hypotrichosis | P11473
                            (related) | 
| H01143 | Vitamin D-dependent rickets | P11473
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D008114 | Liver Neoplasms, Experimental | C00000918 C00000919 | 
| D006528 | Carcinoma, Hepatocellular | C00000919 | 
| D003110 | Colonic Neoplasms | C00000918 | 
| D003921 | Diabetes Mellitus, Experimental | C00000918 | 
| D003924 | Diabetes Mellitus, Type 2 | C00000918 | 
| D000230 | Adenocarcinoma | C00000918 | 
| D015427 | Reperfusion Injury | C00000918 | 
| D007939 | Leukemia L1210 | C00003776 | 
| D014605 | Uveitis | C00003776 | 
| D000435 | Alcoholic Intoxication | C00000919 | 
| D001145 | Arrhythmias, Cardiac | C00000919 | 
| D053627 | Asthenozoospermia | C00000919 | 
| D002545 | Brain Ischemia | C00000919 | 
| D003092 | Colitis | C00000918 | 
| D002318 | Cardiovascular Diseases | C00000919 | 
| D003930 | Diabetic Retinopathy | C00000919 | 
| D056486 | Drug-Induced Liver Injury | C00000919 | 
| D006526 | Hepatitis C | C00000919 | 
| D015658 | HIV Infections | C00000919 | 
| D006986 | Hypervitaminosis A | C00000919 | 
| D008107 | Liver Diseases | C00000919 | 
| D008113 | Liver Neoplasms | C00000919 | 
| D008175 | Lung Neoplasms | C00000919 | 
| D009369 | Neoplasms | C00000919 | 
| D009845 | Oligospermia | C00000919 | 
| D013272 | Stomach Diseases | C00000919 | 
| D013276 | Stomach Ulcer | C00000919 |